Electrolytes & Cardiac Excitability — Electrolyte effects on cardiac excitability (conceptual) - Pathophysiology

SECTION 1

Historical Context & Motivation

The relationship between electrolytes and cardiac function was not appreciated until physiologists began to study the electrical properties of excitable tissue. In the mid-nineteenth century, researchers observed that isolated frog hearts ceased to beat when perfused with distilled water yet resumed rhythmic contractions when an appropriate salt solution was restored. These early experiments suggested that the ionic composition of extracellular fluid was not merely a passive medium but an active determinant of cardiac rhythmicity. Understanding this history illuminates why clinicians today monitor serum electrolytes with such urgency in acutely ill patients—electrolyte derangements remain among the most rapidly lethal and most rapidly correctable causes of cardiac arrest.

1883 • Ringer's Solution

Sydney Ringer demonstrated that a balanced solution of sodium, potassium, and calcium chloride was necessary to sustain rhythmic contractions in isolated frog hearts, establishing the concept of ionic milieu as essential for cardiac excitability.

1902 • Bernstein's Membrane Theory

Julius Bernstein proposed that the resting membrane potential arose from selective potassium permeability, providing a biophysical basis for excitability.

1952 • Hodgkin–Huxley Model

Alan Hodgkin and Andrew Huxley quantified voltage-gated sodium and potassium currents in the squid giant axon, creating the mathematical framework later adapted to cardiac myocytes.

1960s • Cardiac Action Potential Phases Defined

Electrophysiologists characterized the five phases (0–4) of the ventricular cardiac action potential, linking each phase to specific ion channels and establishing the foundation for understanding arrhythmias.

1980s–Present • Molecular Channel Biology

Cloning and crystallography of ion channels (Na_V1.5, Ca_V1.2, K_ir) revealed how electrolyte concentrations modulate channel gating, linking molecular biology directly to clinical ECG findings.

The central question this lesson addresses is deceptively simple: How do changes in extracellular electrolyte concentrations alter the cardiac action potential, and why do those alterations produce the ECG abnormalities and arrhythmias seen in clinical practice? Answering this question requires integrating knowledge of membrane biophysics, ion channel physiology, and the electrocardiographic manifestations of electrolyte imbalance.

SECTION 2

Core Principles of Cardiac Excitability

Cardiac excitability depends on the interplay between ion concentrations across the myocyte membrane and the behavior of voltage-gated ion channels. The four electrolytes of greatest clinical significance are potassium (K⁺), calcium (Ca²⁺), sodium (Na⁺), and magnesium (Mg²⁺). Each influences distinct phases of the cardiac action potential and therefore produces characteristic clinical manifestations when deranged. The following core principles provide the conceptual scaffolding for understanding those effects.

Resting Membrane Potential Is Set by K⁺

The resting membrane potential of cardiac myocytes (approximately −90 mV in ventricular cells) is determined primarily by the K⁺ equilibrium potential because the membrane at rest is most permeable to potassium. Changes in extracellular K⁺ shift the resting potential toward or away from threshold.

Threshold & Depolarization Depend on Na⁺

Phase 0 of the ventricular action potential reflects the rapid influx of Na⁺ through voltage-gated sodium channels (Na_V1.5). The rate and amplitude of this upstroke determine conduction velocity.

Plateau Phase Is Governed by Ca²⁺

During phase 2, inward L-type calcium current (I_Ca,L) balances outward potassium current, sustaining the plateau. The duration of this phase determines the QT interval on the ECG.

Repolarization Relies on K⁺ Efflux

Phases 3 and 4 are driven by outward potassium currents (I_Kr, I_Ks, I_K1) that restore the resting membrane potential. Abnormalities in K⁺ concentration directly affect these currents.

Mg²⁺ Is a Membrane Stabilizer

Magnesium modulates multiple ion channels and the Na⁺/K⁺-ATPase. It acts as a physiological calcium antagonist and is critical for maintaining normal potassium and calcium homeostasis intracellularly.

✦

KEY TAKEAWAY

Think of the cardiac myocyte as a room with several doors (ion channels) that open and close in sequence. Potassium sets how tightly the doors are latched at rest, sodium kicks the first door open, calcium holds it open during the plateau, and magnesium oils the hinges so everything swings smoothly. Change the concentration of any one ion and you change how the entire door-opening sequence behaves—potentially producing arrhythmias.

SECTION 3

The Cardiac Action Potential & Ion Contributions

The following diagram illustrates the five phases of a ventricular cardiac action potential (phases 0 through 4), with each phase color-coded to the dominant ion current. Understanding which ion drives each phase is essential for predicting how electrolyte derangements will alter the waveform and, consequently, the ECG.

The ventricular action potential spans roughly 200–300 ms. Phase 0 (cyan) shows the rapid sodium-driven upstroke. Phase 2 (pink) is the calcium-dependent plateau. Phase 3 (amber) represents potassium-driven repolarization. Phase 4 (violet) is the stable resting potential maintained by I_K1.

Each phase of the action potential maps to a specific segment of the surface ECG. Phase 0 corresponds to the QRS complex, the plateau (phase 2) underlies the ST segment, and phase 3 repolarization produces the T wave. The interval from the beginning of the QRS to the end of the T wave—the QT interval—therefore reflects the total duration of ventricular depolarization and repolarization. This correlation is what makes the ECG such a powerful bedside tool for detecting electrolyte abnormalities: changes in ion concentrations alter the shape and timing of the action potential, and those changes are faithfully transmitted to the surface recording.

SECTION 4

Mechanistic Framework — The Nernst & Goldman Equations

The conceptual basis for predicting how electrolyte changes affect membrane potential rests on two fundamental equations. While this lesson is primarily conceptual, understanding the mathematical underpinnings clarifies why small changes in extracellular potassium, for example, produce disproportionately large effects on cardiac excitability.

NERNST EQUATION

E_ion = (RT / zF) × ln([ion]_outside / [ion]_inside)

Where E_ion = equilibrium potential for that ion, R = gas constant, T = absolute temperature, z = ion valence, F = Faraday's constant. At 37 °C for a monovalent cation, the simplified form becomes E_K ≈ −61.5 × log([K⁺]_o / [K⁺]_i).

The Nernst equation calculates the equilibrium potential for a single ion. However, real membranes are permeable to multiple ions simultaneously. The Goldman-Hodgkin-Katz (GHK) equation accounts for this by weighting each ion's contribution by its relative membrane permeability (P). At rest, permeability to K⁺ dominates overwhelmingly; during phase 0, permeability to Na⁺ transiently dominates. This is why the resting membrane potential sits close to E_K (≈ −90 mV) while the peak of phase 0 approaches E_Na (≈ +60 mV).

GOLDMAN-HODGKIN-KATZ EQUATION (SIMPLIFIED)

V_m = (RT/F) × ln((P_K[K⁺]_o + P_Na[Na⁺]_o + P_Cl[Cl⁻]_i) / (P_K[K⁺]_i + P_Na[Na⁺]_i + P_Cl[Cl⁻]_o))

Permeability ratios (P) determine which ion 'wins.' At rest, P_K >> P_Na, so V_m ≈ E_K. A rise in [K⁺]_o makes the ratio closer to 1, making $V_m$ less negative (depolarized).

⚠

Clinical Link

When serum K⁺ rises from 4.0 to 6.5 mEq/L, the Nernst equation predicts that E_K shifts from approximately −94 mV toward −80 mV. This partial depolarization first brings the resting potential closer to threshold (increasing excitability transiently) and then, at higher levels, inactivates sodium channels (decreasing excitability profoundly), leading to the sine-wave pattern on ECG that precedes cardiac arrest.

SECTION 5

Detailed Breakdown — Each Electrolyte's Effect on Cardiac Excitability

Each of the four major electrolytes has distinct—and in some cases, opposite—effects on the cardiac action potential. The diagram below summarizes the ECG manifestations of hypo- and hyperkalemia, the most clinically consequential derangement, alongside the effects of calcium and magnesium abnormalities.

Summary of electrolyte derangements. Hypokalemia prolongs the QT and produces U waves. Hyperkalemia peaks T waves and widens QRS. Calcium primarily affects the QT interval (prolonged in hypocalcemia, shortened in hypercalcemia). Magnesium depletion often accompanies potassium depletion and must be corrected first.

Electrolyte	Low State	High State	Primary AP Phase Affected	Key ECG Change
K⁺	Hyperpolarization, ↑ AP duration, U waves	Depolarization, ↓ AP duration, peaked T	Phase 3 & 4 (repolarization & resting)	T wave and QRS morphology
Ca²⁺	Prolonged plateau, ↑ QT	Shortened plateau, ↓ QT	Phase 2 (plateau)	QT interval length
Na⁺	↓ Upstroke velocity, ↓ conduction	↑ Upstroke velocity (minimal clinical effect)	Phase 0 (depolarization)	QRS width
Mg²⁺	↑ Excitability, mimics hypokalemia	↓ Excitability, conduction block	Modulates phases 2, 3, and 4	QT prolongation; PR prolongation (high)

Summary of electrolyte effects on the cardiac action potential and ECG

SECTION 6

Worked Example — Hyperkalemia and ECG Progression

Consider a 68-year-old patient with chronic kidney disease who presents with serum K⁺ of 7.2 mEq/L and the following ECG findings: peaked T waves, widened QRS, and absent P waves. Let us trace the pathophysiology step by step.

Clinical Reasoning: Hyperkalemia ECG Progression

1
Step 1 — Assess the Nernst Effect

With normal intracellular K⁺ ≈ 150 mEq/L and extracellular K⁺ rising from 4.0 to 7.2 mEq/L, the Nernst equation tells us E_K shifts from approximately −94 mV to approximately −79 mV. Because the resting membrane potential follows E_K, the membrane partially depolarizes.

Resting potential shifts from −90 mV toward −80 mV → partial depolarization
2
Step 2 — Predict Na⁺ Channel Behavior

Voltage-gated Na⁺ channels (Na_V1.5) have three states: resting (closed but available), open, and inactivated. At a resting potential of −80 mV, a significant fraction of Na⁺ channels enter the inactivated state and are unavailable for activation. This reduces the number of channels that open during phase 0.

Fewer available Na⁺ channels → decreased phase 0 upstroke velocity → slowed conduction
3
Step 3 — Map to ECG Findings

The accelerated K⁺ efflux during repolarization (phase 3) shortens the action potential duration, producing peaked T waves — the earliest ECG sign, typically appearing at K⁺ > 5.5 mEq/L. The decreased phase 0 upstroke velocity slows intraventricular conduction, widening the QRS complex (typically K⁺ > 6.5). The atrial myocardium is more sensitive to hyperkalemia than the ventricular myocardium, so P waves flatten and eventually disappear as atrial conduction fails, often before the QRS widens maximally.

Progressive ECG: peaked T → ↓P waves → widened QRS → sine wave → VF/asystole
4
Step 4 — Therapeutic Rationale

Intravenous calcium (calcium gluconate or calcium chloride) does not lower serum K⁺ but stabilizes the cardiac membrane by raising the threshold potential, effectively increasing the gap between resting potential and threshold. This is why calcium is the first-line intervention in life-threatening hyperkalemia—it buys time while definitive potassium-lowering therapies (insulin/glucose, sodium bicarbonate, dialysis) take effect.

IV calcium raises threshold potential → restores excitability margin → prevents arrhythmia

SECTION 7

Clinical Comparisons — Hypo vs. Hyper States

A common source of confusion for healthcare students is distinguishing between the effects of low versus high concentrations of the same electrolyte. The table below provides a side-by-side comparison that highlights the mechanistic logic. Notice how hypo- and hyperkalemia both increase arrhythmia risk—but through fundamentally different mechanisms.

Feature	Hypokalemia	Hyperkalemia
Resting membrane potential	More negative (hyperpolarized)	Less negative (depolarized)
AP duration	Prolonged (↓ I_K1 repolarizing current)	Shortened (↑ K⁺ efflux gradient)
Na⁺ channel availability	Normal to increased (channels fully recovered)	Decreased (inactivated by depolarization)
Conduction velocity	Normal or slightly increased	Decreased (widened QRS)
Primary arrhythmia risk	Triggered activity, Torsades de Pointes	Conduction block, VF, asystole
ECG hallmark	Flat T, prominent U wave, ST depression	Peaked T, wide QRS, absent P wave

Comparison of hypokalemia and hyperkalemia effects on cardiac excitability

✦

KEY TAKEAWAY

Think of the difference between hypo- and hyperkalemia as analogous to adjusting the tension on a guitar string. Hypokalemia over-tightens the string (hyperpolarization), making it more likely to vibrate erratically when plucked—analogous to triggered arrhythmias like Torsades de Pointes. Hyperkalemia loosens the string (depolarization) so much that it can barely vibrate at all—analogous to conduction failure and eventually cardiac standstill. Both extremes are dangerous, but the mechanisms are opposite.

SECTION 8

Connections to Advanced Cardiac Electrophysiology

The conceptual framework presented in this lesson forms the foundation for more advanced topics in cardiac electrophysiology, including antiarrhythmic drug pharmacology, inherited channelopathies, and computational cardiac modeling. Each of these advanced domains relies on the same principles—ion channel behavior shaped by electrochemical gradients—but adds layers of complexity.

Concept in This Lesson	Advanced Extension
K⁺ shifts resting membrane potential	Vaughan-Williams Class III antiarrhythmics (amiodarone, sotalol) block K⁺ channels to prolong refractoriness—understanding K⁺ physiology is essential for predicting drug effects and toxicities
Ca²⁺ governs plateau duration	Class IV antiarrhythmics (verapamil, diltiazem) and dihydropyridines block L-type Ca²⁺ channels; inherited Long QT Syndrome (LQT8/Timothy Syndrome) involves gain-of-function Ca_V1.2 mutations
Na⁺ determines phase 0 upstroke	Class I antiarrhythmics block Na⁺ channels; Brugada Syndrome arises from loss-of-function Na_V1.5 mutations (SCN5A gene)
Mg²⁺ as membrane stabilizer	Mg²⁺ modulates NMDA receptors and is used in eclampsia, asthma, and neuroprotection—demonstrating the cross-system relevance of electrolyte physiology

Mapping foundational electrolyte concepts to advanced electrophysiology

As you progress into pharmacology and clinical rotations, you will encounter these same electrolyte-channel interactions repeatedly. Antiarrhythmic drugs essentially mimic electrolyte disturbances in a targeted fashion: Class I agents reduce Na⁺ current (like hyponatremia slows phase 0), Class III agents reduce K⁺ current (like hypokalemia prolongs repolarization), and Class IV agents reduce Ca²⁺ current (like hypocalcemia lengthens the plateau). This insight—that drugs and electrolyte imbalances act through the same ion channels—explains why electrolyte abnormalities potentiate antiarrhythmic drug toxicity and why correcting electrolytes is always the first step in managing arrhythmias.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient's serum potassium level drops from 4.0 mEq/L to 2.8 mEq/L. In which direction does the resting membrane potential of ventricular myocytes shift, and why does this paradoxically increase the risk of arrhythmias despite moving the membrane further from threshold?

Show answer

Hypokalemia increases the K⁺ concentration gradient across the membrane (intracellular K⁺ remains ≈ 150 mEq/L while extracellular K⁺ falls), driving the resting membrane potential to a more negative value (hyperpolarization). Although this moves the resting potential further from the threshold for Na⁺ channel activation, the decreased extracellular K⁺ also reduces the outward repolarizing K⁺ currents (I_K1, I_Kr), prolonging the action potential duration and the QT interval. This prolongation creates a window for early afterdepolarizations (EADs), which can trigger re-entrant arrhythmias such as Torsades de Pointes.

Question 2: BASIC CALCULATION

Using the simplified Nernst equation at 37 °C (E_K = −61.5 × log([K⁺]_o / [K⁺]_i)), calculate the approximate potassium equilibrium potential when extracellular K⁺ = 4.0 mEq/L and intracellular K⁺ = 150 mEq/L. Then recalculate for extracellular K⁺ = 8.0 mEq/L and comment on the clinical significance of the shift.

Show answer

At [K⁺]_o = 4.0: E_K = −61.5 × log(4.0/150) = −61.5 × log(0.0267) = −61.5 × (−1.574) ≈ −96.8 mV. At [K⁺]_o = 8.0: E_K = −61.5 × log(8.0/150) = −61.5 × log(0.0533) = −61.5 × (−1.273) ≈ −78.3 mV. The shift of approximately 18 mV in the depolarizing direction is profoundly significant because a resting potential of −78 mV causes substantial inactivation of Na_V1.5 channels, slowing conduction and producing the widened QRS and eventual sine-wave pattern characteristic of severe hyperkalemia.

Question 3: INTERMEDIATE

A patient with hypocalcemia (serum Ca²⁺ = 6.5 mg/dL) has a prolonged QT interval on ECG. Explain which specific segment of the QT interval is prolonged and the underlying mechanism at the level of the cardiac action potential. How does this differ from QT prolongation caused by hypokalemia?

Show answer

In hypocalcemia, the prolonged QT is primarily due to lengthening of the ST segment, which corresponds to the plateau phase (phase 2) of the ventricular action potential. Reduced extracellular Ca²⁺ decreases the inward L-type calcium current, which paradoxically delays completion of the plateau because the balance between inward Ca²⁺ current and outward K⁺ current takes longer to resolve in favor of repolarization. In contrast, hypokalemia prolongs the QT interval by slowing phase 3 repolarization (the T wave component) because reduced extracellular K⁺ decreases outward repolarizing currents. Clinically, this distinction matters because hypocalcemia-related QT prolongation shows a long, flat ST segment with a normal T wave shape, while hypokalemia-related QT prolongation shows flattened T waves, ST depression, and prominent U waves.

Question 4: APPLIED

A 45-year-old patient on furosemide (a loop diuretic) presents with muscle weakness, ECG showing U waves, prolonged QT, and premature ventricular contractions. Labs reveal: K⁺ = 2.9 mEq/L, Mg²⁺ = 1.2 mg/dL (low), Ca²⁺ = 9.0 mg/dL (normal). Design a prioritized electrolyte correction plan and explain the pathophysiological rationale for the order of correction.

Show answer

The correction plan should prioritize magnesium replacement first, followed by potassium. The rationale is as follows: (1) Hypomagnesemia impairs the Na⁺/K⁺-ATPase, which is the primary mechanism for maintaining intracellular K⁺ stores. Without adequate Mg²⁺, administered potassium will simply be excreted renally rather than being retained intracellularly, making K⁺ repletion futile. (2) Mg²⁺ directly stabilizes the cardiac membrane and is the first-line treatment for Torsades de Pointes, the arrhythmia this patient is at risk for. Administer IV magnesium sulfate (1–2 g over 15–30 minutes), then begin IV potassium chloride infusion (10–20 mEq/hour via central line given the severity). Continuous cardiac monitoring is essential because both the hypokalemia itself and the potassium infusion carry arrhythmia risk. The calcium level is normal and does not require intervention, but calcium should be rechecked after magnesium is repleted since Mg²⁺ affects Ca²⁺ homeostasis via PTH secretion.

Question 5: CRITICAL THINKING

Explain the apparent paradox: both hypokalemia and hyperkalemia increase the risk of lethal arrhythmias, yet they move the resting membrane potential in opposite directions. Integrate the concepts of afterdepolarizations, conduction velocity, and re-entry to construct a unified explanation of why both extremes are proarrhythmic.

Show answer

The resolution of this paradox lies in recognizing that arrhythmias can arise through fundamentally different mechanisms, and the two extremes of potassium imbalance each preferentially activate a different proarrhythmic pathway. Hypokalemia hyperpolarizes the resting membrane potential and prolongs repolarization by reducing outward K⁺ currents. The prolonged action potential creates conditions favorable for early afterdepolarizations (EADs)—spontaneous depolarizations during phase 2 or 3—because L-type Ca²⁺ channels have time to recover from inactivation during the abnormally long plateau. These EADs serve as triggers for polymorphic ventricular tachycardia (Torsades de Pointes). Hyperkalemia, on the other hand, depolarizes the resting membrane potential, inactivating Na⁺ channels and decreasing conduction velocity. Slowed conduction creates heterogeneity in tissue excitability—some regions remain excitable while others are refractory—establishing the substrate for re-entrant circuits. Additionally, the differential sensitivity of atrial versus ventricular tissue to hyperkalemia creates further electrophysiological heterogeneity. Thus, hypokalemia primarily generates arrhythmias through abnormal impulse formation (triggered activity), while hyperkalemia primarily generates arrhythmias through abnormal impulse conduction (re-entry and conduction failure). Both are lethal, but the ECG patterns, the arrhythmia subtypes, and the treatments differ markedly.

SUMMARY

Lesson Summary — Electrolytes & Cardiac Excitability

Summary

Cardiac excitability is governed by four key electrolytes, each influencing specific phases of the action potential. Potassium is the most clinically significant: it determines the resting membrane potential via the Nernst equation and dominates phases 3 and 4 of the action potential. Hyperkalemia depolarizes the resting membrane, inactivates Na⁺ channels, and produces peaked T waves progressing to widened QRS and sine wave. Hypokalemia hyperpolarizes the membrane, prolongs repolarization, and creates conditions for Torsades de Pointes via early afterdepolarizations.

Calcium governs the plateau phase (phase 2) and directly modulates the QT interval—prolonged in hypocalcemia, shortened in hypercalcemia. Sodium drives the phase 0 upstroke and determines conduction velocity. Magnesium serves as a physiological membrane stabilizer and must be corrected before potassium repletion can be effective. These foundational concepts directly inform the Vaughan-Williams classification of antiarrhythmic drugs and the clinical management of arrhythmias in acute care settings.